Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Iberdomide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bristol Myers Lines Up Many Launches For India With 'AI' Speed
    Bristol Myers Lines Up Many Launches For India With 'AI' Speed

    24 Dec 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bristol-myers-lines-up-many-launches-for-india-with-ai-speed/articleshow/126147041.cms

    ECONOMICTIMES
    24 Dec 2025
    Share Share
    Bristol Myers Squibb Showcases Hematology Pipeline At ASH 2025
    Bristol Myers Squibb Showcases Hematology Pipeline At ASH 2025

    01 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251126896757/en/Bristol-Myers-Squibb-Data-at-ASH-2025-Showcase-Potential-of-Hematology-Pipeline-and-Build-Momentum-for-Next-Generation-Portfolio

    BUSINESSWIRE
    01 Dec 2025
    Share Share
    BMS Midtrial Endpoint Addition Secures Phase 3 Win in Myeloma
    BMS Midtrial Endpoint Addition Secures Phase 3 Win in Myeloma

    24 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/bristol-myers-mid-trial-endpoint-addition-secures-phase-3-win-multiple-myeloma

    FIERCE BIOTECH
    24 Sep 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.